economy
Those in the know know the disconnect between the economy and the volatile stock market; discover the reality about this complex relationship.
North America Silicone Market Size and Forecast 2025–2033. AI-Generated.
North America Silicone Market Outlook The North America Silicone Market is entering a phase of steady and resilient growth, supported by expanding applications across construction, healthcare, electronics, transportation, and personal care industries. According to Renub Research, the market is expected to grow from US$ 5.94 billion in 2024 to US$ 9.22 billion by 2033, registering a compound annual growth rate (CAGR) of 5.00% from 2025 to 2033.
By shibansh kumar5 days ago in Trader
North America Drone Market Size and Forecast 2025–2033. AI-Generated.
Introduction: Drones Move from Niche to Necessity Over the last decade, drones—also known as unmanned aerial vehicles (UAVs)—have evolved from hobbyist gadgets and military tools into essential assets across multiple industries. In North America, this transformation has been especially visible. What was once a niche technology is now deeply embedded in sectors such as agriculture, construction, logistics, energy, media, and public safety.
By Sakshi Sharma5 days ago in Trader
Europe Anticoagulants Market Size and Forecast 2025–2033. AI-Generated.
Introduction: A Market at the Heart of Modern Cardiovascular Care The Europe anticoagulants market is entering a decisive decade, shaped by demographic change, lifestyle-related disease burdens, and rapid pharmaceutical innovation. Valued at US$ 11.63 billion in 2024, the market is expected to reach US$ 23.68 billion by 2033, expanding at a CAGR of 8.22% from 2025 to 2033. This strong growth reflects not only rising clinical need, but also a fundamental transformation in how blood clotting disorders are treated across the continent.
By Sakshi Sharma5 days ago in Trader
North America Clinical Trials Market Size and Forecast 2025–2033. AI-Generated.
Introduction The North America Clinical Trials Market is entering a decisive growth phase as pharmaceutical and biotechnology companies race to develop safer, more effective, and more personalized treatments. According to Renub Research, the market is expected to grow from US$ 20.07 billion in 2024 to US$ 33.91 billion by 2033, expanding at a CAGR of 6.00% from 2025 to 2033. This steady rise reflects longer clinical trial cycles, increasing demand for innovative therapies, and the growing burden of chronic and infectious diseases such as cancer, diabetes, and post-pandemic viral conditions.
By shibansh kumar5 days ago in Trader











